In 2019, it will be 20 years of history of this traditional Joint Meetings, founded in 1999 by Prof. G. Ronsivalle (Italy) together with Prof. A. Lipkowski (Poland) and Prof. G. Toth (Hungary). On behalf of National Chemical Societies of Italy, Poland and Hungary, Prof G. Ronsivalle together with Prof. Z. Chilmonczyk (Poland) and Prof. P. Matyus (Hungary) organized the first meeting in Taormina in 1999, particularly to promote Medicinal Chemistry, attract young scientists and foster relationships between medicinal chemists of the participating countries. After Taormina, JMMC was held in Budapest 2001, Krakow 2003, Vienna 2005, Portorož 2007, Budapest 2009, Catania 2011, Lublin 2013, Athens 2015 and Dubrovnik 2017. Since the first meeting, number of participating countries has increased to nine – Austria, Croatia, Czech Republic, Greece, Hungary, Italy, Poland, Slovakia and Slovenia. The success of last 10th JMMC-2017 (249 participants from 28 countries) illustrates an interest of this kind of meetings. We are pleased to invite medicinal chemists from all over the world, not only participating countries, to come, stimulate discussion in drug discovery and development and to promote collaboration between medicinal chemistry scientists, both young and experienced.

Confirmed Speakers

• Dr. Tomas Cihlar (Gilead Sciences, United States)
• Prof. Michal Hocek (Institute of Organic Chemistry and Biochemistry of the CAS, Czech Republic)
• Assoc. Prof. Dr. Janez Ilas (University of Ljubljana, Slovenia)
• Prof. Yoel Rodríguez (Hostos Community College of CUNY, United States)
• Prof. Dr. Sanja Tomic (Ruder Boskovic Institute, Croatia)

Contact person: Martin Dolezal
Tel: +420495067389
Email: dolezalm@faf.cuni.cz

The French Medicinal Chemistry Society (Société de Chimie Thérapeutique - SCT) is pleased to invite you to Nantes, France on July 3-5, 2019 for the 55th edition of the International Conference on Medicinal Chemistry (RICT 2019).

The congress will be devoted to “Interfacing Chemical Biology and Drug Discovery” and the main topics will be:

• New Breakthroughs in Targeting PPIs
• Recent Trends in Infectious Diseases Drug Development
• Tackling New Challenges in Antibody-drug Conjugates
• Inspired by Nature
• Artificial Intelligence in Drug Discovery : Reality or Hype
• Case studies: from target validation to novel drugs (all therapeutic areas included)

As for previous editions of RICT, the scientific committee will ensure the high quality and diversity of the scientific programme together with the accessibility of the meeting to PhD/post-doc and local Master students. For the latter, an advantageous registration fee is proposed. Moreover, a special career session will be organised with industrial and academic participants.

During the meeting, you will have the opportunity to listen to the recipient of the 2019 Paul Ehrlich Award and to the recipient of the Pierre Fabre Award for Therapeutic Innovation

In addition, a poster session will provide the opportunity for all participants to present their current results. “Best poster” prizes will be attributed at the end of the meeting.

For more information please contact: secretariat@ldorganisation.com